1072 related articles for article (PubMed ID: 33231507)
1. Novel Insights Into the Role of N6-Methyladenosine RNA Modification in Bone Pathophysiology.
Chen J; Tian Y; Zhang Q; Ren D; Zhang Q; Yan X; Wang L; He Z; Zhang W; Zhang T; Yuan X
Stem Cells Dev; 2021 Jan; 30(1):17-28. PubMed ID: 33231507
[TBL] [Abstract][Full Text] [Related]
2. Novel insights into the interaction between N6-methyladenosine methylation and noncoding RNAs in musculoskeletal disorders.
Han J; Kong H; Wang X; Zhang XA
Cell Prolif; 2022 Oct; 55(10):e13294. PubMed ID: 35735243
[TBL] [Abstract][Full Text] [Related]
3. Novel insights into the interplay between m
Yi YC; Chen XY; Zhang J; Zhu JS
Mol Cancer; 2020 Aug; 19(1):121. PubMed ID: 32767982
[TBL] [Abstract][Full Text] [Related]
4. N6-methyladenosine RNA modification and its interaction with regulatory non-coding RNAs in colorectal cancer.
Ge Y; Liu T; Wang C; Zhang Y; Xu S; Ren Y; Feng Y; Yin L; Pu Y; Liang G
RNA Biol; 2021 Nov; 18(sup2):551-561. PubMed ID: 34674600
[TBL] [Abstract][Full Text] [Related]
5. N6-methyladenosine (m6A) modification in osteosarcoma: expression, function and interaction with noncoding RNAs - an updated review.
Zhang Y; Xu Y; Bao Y; Luo Y; Qiu G; He M; Lu J; Xu J; Chen B; Wang Y
Epigenetics; 2023 Dec; 18(1):2260213. PubMed ID: 37766615
[TBL] [Abstract][Full Text] [Related]
6. Relevance of N6-methyladenosine regulators for transcriptome: Implications for development and the cardiovascular system.
Sweaad WK; Stefanizzi FM; Chamorro-Jorganes A; Devaux Y; Emanueli C;
J Mol Cell Cardiol; 2021 Nov; 160():56-70. PubMed ID: 33991529
[TBL] [Abstract][Full Text] [Related]
7. The role of N6-methyladenosine (m6A) in eye diseases.
Gao JF; Zhang L
Mol Biol Rep; 2021 Aug; 48(8):6145-6150. PubMed ID: 34331665
[TBL] [Abstract][Full Text] [Related]
8. N6-Methyladenosine modification of lincRNA 1281 is critically required for mESC differentiation potential.
Yang D; Qiao J; Wang G; Lan Y; Li G; Guo X; Xi J; Ye D; Zhu S; Chen W; Jia W; Leng Y; Wan X; Kang J
Nucleic Acids Res; 2018 May; 46(8):3906-3920. PubMed ID: 29529255
[TBL] [Abstract][Full Text] [Related]
9. Involvement of N6-methyladenosine modifications of long noncoding RNAs in systemic lupus erythematosus.
Wu J; Deng LJ; Xia YR; Leng RX; Fan YG; Pan HF; Ye DQ
Mol Immunol; 2022 Mar; 143():77-84. PubMed ID: 35051888
[TBL] [Abstract][Full Text] [Related]
10. N6-methyladenosine RNA modification: A promising regulator in central nervous system injury.
Wang Q; Liang Y; Luo X; Liu Y; Zhang X; Gao L
Exp Neurol; 2021 Nov; 345():113829. PubMed ID: 34339678
[TBL] [Abstract][Full Text] [Related]
11. N6-methyladenosine modification in mRNA: machinery, function and implications for health and diseases.
Maity A; Das B
FEBS J; 2016 May; 283(9):1607-30. PubMed ID: 26645578
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA NEAT1 promotes bone metastasis of prostate cancer through N6-methyladenosine.
Wen S; Wei Y; Zen C; Xiong W; Niu Y; Zhao Y
Mol Cancer; 2020 Dec; 19(1):171. PubMed ID: 33308223
[TBL] [Abstract][Full Text] [Related]
13. The interplay between m6A RNA methylation and noncoding RNA in cancer.
Ma S; Chen C; Ji X; Liu J; Zhou Q; Wang G; Yuan W; Kan Q; Sun Z
J Hematol Oncol; 2019 Nov; 12(1):121. PubMed ID: 31757221
[TBL] [Abstract][Full Text] [Related]
14. Functions of N6-methyladenosine and its role in cancer.
He L; Li H; Wu A; Peng Y; Shu G; Yin G
Mol Cancer; 2019 Dec; 18(1):176. PubMed ID: 31801551
[TBL] [Abstract][Full Text] [Related]
15. Functions of RNA N6-methyladenosine modification in cancer progression.
Chen B; Li Y; Song R; Xue C; Xu F
Mol Biol Rep; 2019 Apr; 46(2):2567-2575. PubMed ID: 30911972
[TBL] [Abstract][Full Text] [Related]
16. RNA N6-methyladenosine methylation and skin diseases.
Yu Y; Lu S; Jin H; Zhu H; Wei X; Zhou T; Zhao M
Autoimmunity; 2023 Dec; 56(1):2167983. PubMed ID: 36708146
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic regulation of mRNA N6-methyladenosine modifications in mammalian gametogenesis.
Fang F; Wang X; Li Z; Ni K; Xiong C
Mol Hum Reprod; 2021 May; 27(5):. PubMed ID: 33823008
[TBL] [Abstract][Full Text] [Related]
18. The relationship between the network of non-coding RNAs-molecular targets and N6-methyladenosine modification in tumors of urinary system.
Li R; Zhu C; Wang Y; Wang X; Wang Y; Wang J; Wang K
Cell Death Dis; 2024 Apr; 15(4):275. PubMed ID: 38632251
[TBL] [Abstract][Full Text] [Related]
19. Functions of RNA N6-methyladenosine modification in cancer progression.
Chen B; Li Y; Song R; Xue C; Xu F
Mol Biol Rep; 2019 Feb; 46(1):1383-1391. PubMed ID: 30788764
[TBL] [Abstract][Full Text] [Related]
20. The roles of N6-methyladenosine and its target regulatory noncoding RNAs in tumors: classification, mechanisms, and potential therapeutic implications.
Liu Z; Gao L; Cheng L; Lv G; Sun B; Wang G; Tang Q
Exp Mol Med; 2023 Mar; 55(3):487-501. PubMed ID: 36854773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]